Characteristics analyses and tumor staging proposal for primary malignant melanoma of the esophagus: a retrospective study
Diseases of the Esophagus · 2025
DOI: 10.1093/dote/doaf009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases of the Esophagus, 2025. Verfasst von Weijie Ye und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Cente…. Hauptthemen laut MEDLINE: Melanoma, Neoplasm Staging, Esophageal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Guangdong Esophageal Cancer Institute, Sun Yat-sen University.
Abstract (Originalsprache)
Primary malignant melanoma of the esophagus (PMME) is a malignant tumor with a poor prognosis. This study aimed to conduct survival analysis for patients with PMME and propose a staging system for PMME. Data from 179 patients were compiled for survival analysis and to propose a staging system for PMME. Survival analysis was conducted using the Kaplan–Meier method, log-rank test, and Cox proportional hazards model. The median OS of the 179 patients with PMME was 20.0 months. The 1-, 3-, and 5-year survival rates were 67.0%, 35.0%, and 17.0%. In the pooled analysis of 179 patients, significant differences in OS were observed between patients with tumors invading the lamina propria or muscularis mucosae (T1a) and deeper layers (T1b, T2, T3, T4) (P < 0.001). Significant differences in OS were observed between patients with no regional lymph node metastasis and those with one or more regional lymph node metastases (P < 0.001). PD-1 inhibitors significantly improved 3-year OS for patients with the pT1b-4 N+ stage (P = 0.020). The proposed staging system for PMME is as follows: (1) Stage I: T1aN0M0 (2) Stage II: T1b-4N0M0 and T1N1M0; Stage III: T2-4N1M0 and TxNxM1(P < 0.001). The lower T-stage and no lymph node metastasis indicated better prognosis. Surgery could be considered an effective treatment for patients with early-stage PMME. The effectiveness of surgery as a treatment for advanced-stage patients remained unclear and required further research. However, PD-1 inhibitors might improve the 3-year OS for advanced-stage patients. Furthermore, the tumor, node, metastasis staging system for PMME was proposed, and could be valuable in guiding prognostic predictions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Clinical Research Center f…
- Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, China.
- Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou City, China.
Förderung
- Guangdong Esophageal Cancer Institute
- Sun Yat-sen University
Zitieren
APA
Ye, W., Leng, C., Chen, J., Mai, Z., Liu, N., Zhang, S., Fu, J., & Liu, Q. (2025). Characteristics analyses and tumor staging proposal for primary malignant melanoma of the esophagus: a retrospective study. Diseases of the Esophagus. https://doi.org/10.1093/dote/doaf009
Vancouver
Ye W, Leng C, Chen J, Mai Z, Liu N, Zhang S, et al. Characteristics analyses and tumor staging proposal for primary malignant melanoma of the esophagus: a retrospective study. Diseases of the Esophagus. 2025. doi:10.1093/dote/doaf009
BibTeX
@article{Ye2025,
author = {Ye, Weijie and Leng, Changsen and Chen, Junying and Mai, Zihang and Liu, Nianjin and Zhang, Shuishen and Fu, Jianhua and Liu, Qianwen},
title = {Characteristics analyses and tumor staging proposal for primary malignant melanoma of the esophagus: a retrospective study},
journal = {Diseases of the Esophagus},
year = {2025},
doi = {10.1093/dote/doaf009}
}
EUVIMED